A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis

NCT07747480 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

BIOLOGICAL: Aletekitug

Sponsor

GlaxoSmithKline